The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Why on earth are people so caught up on hypothetical situations. You are literally discussing what will happen in 2/3 months if we don’t get on a trial. What is the point it’s actually mind blowing how much time people waste talking sh*t.
It’s like me sat here saying in a months time we will be sat next to the Christmas tree with a bottle of wine, secured two trials, had a month of solid news and we all are discussing timelines and price predictions.
There’s a lot more chance of my situation playing out than Axe’s yet the board is constantly clogged up with worst case scenario discussions. Just enjoy the days and wait for news stop with the doom and gloom.
@professional you are calling pretty much all investors on this board one of them three insults. If anything that’s just showing how naive you are. Who are you to put investors into your pathetic little groups ?
I am young, very heavily invested, not naive and wonder daily about coms and what’s happening behind the scenes. But guess what ? Moaning like a little ***** on a share discussion board to get random peoples approval is pathetic. I decide to keep my mouth shut and not rant about RM when I don’t have a clue what the chaps doing behind the scenes or how close to signing deals he might be.
https://twitter.com/drericding/status/1589442840031268864?s=46&t=tT6Zfoselttd6eGa7zt7QQ
That is the link you are referring to and that thread just highlights Synairgens opportunity here. If they can prove efficiency in a trial and get to market then the market size in the years to come is phenomenal.
@Tommy Did you mention Synairgen in your original email ?
That is key to which way Staceys reply should be taken in my opinion, just her reply gives no context. If Synairgen wasn’t mentioned by you then I’d say that it’s positive but if it was I’d see her response as a subtle nod maybe we are not going to be on the strive trial otherwise there was no need to go into detail as she did.
It would be interesting to see how the market reacts to a JV should one land one. It’s pointless trying to speculate as there are so many variables of the deal which would change the outcome. For myself, when thinking of the loss in profits that Synairgen would see in a JV it is out weighted by the improved probability of success and faster timeline. Also Synairgen get to keep the lights on a little longer without diluting our already battered shares.
Fingers crossed a deal is all but signed off and we are not waiting much longer.
Viletrader i find you more annoying than all the green boxes I’ve had in the past. I often find myself replying and deleting. You are now getting green binned something I should have done weeks ago. You are annoying, stupid and painful to listen to. Id love to chin you but I can’t so the next best thing is a green bin. Good bye and good night.
Perhaps because the presentation isn’t until after trading hours today today they have no requirement to release an RNS with the contents of the presentation until
Monday morning.
Synairgen are well known for liking the Monday morning approach.
@patagucci I feel exactly the same, way under water, whenever I can top up I do even though the hundreds I can afford now to the 10s of thousand around £2 is a little disheartening I still wish I had more. Our day will come. One day we will look back and wish we bought more. Atleast that what I tell myself and any friends or family who talk down on SNG!
Got to agree doc I’m regretting all the top ups over these last few months. It feels now if we don’t get a JV then they are planning on coming back to market and doing their own trial, that just takes the timelines to another level. If we don’t get on a PT which sounds slim now and don’t get a JV then nothing will happen this winter and this SP will collapse. I wonder where Poly stand in that scenario and what they will do.
I’m going to just try and forget about this now and stop checking in for news of a trial and hope something materialises. GLTA.
I’ve been running a business for 23 years and still learning and get things wrong now. I’d say 20 years developing and trialing a new treatment isn’t exactly out of the ordinary. If they’d had more luck or better judgment on the end points on sprinter then we would no doubt be commercialised and not be having this conversation.
We know they’ve had problems with trials along the way and hopefully they’ve learnt a lot and gathered a lot of data along the way but that’s always going to happen in the industry they are in.
We need another trial everyone knows that, it is what it is at this stage, moaning and complaining isn’t going to make the process go any quicker.